2,866 hedge funds and large institutions have $105B invested in Pfizer in 2024 Q2 according to their latest regulatory filings, with 212 funds opening new positions, 1,179 increasing their positions, 1,238 reducing their positions, and 172 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

5% less repeat investments, than reductions

Existing positions increased: 1,179 | Existing positions reduced: 1,238

1.16% less ownership

Funds ownership: 67.15%65.99% (-1.2%)

40% less call options, than puts

Call options by funds: $2.36B | Put options by funds: $3.9B

Holders
2,866
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
33
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.36B
Puts
$3.9B
Net Calls
Net Calls Change

Top Buyers

1 +$346M
2 +$334M
3 +$233M
4
Citadel Advisors
Citadel Advisors
Florida
+$217M
5
Norges Bank
Norges Bank
Norway
+$199M
Name Holding Trade Value Shares
Change
Change in
Stake
2626
$158K
2627
$157K
2628
$156K
2629
$155K
2630
$154K
2631
$152K
2632
$151K
2633
$150K
2634
$150K
2635
$149K
2636
$148K
2637
$147K
2638
$146K
2639
$146K
2640
$143K
2641
$142K
2642
$142K
2643
$138K
2644
$137K
2645
$137K
2646
$136K
2647
$135K
2648
$134K
2649
$133K
2650
$129K